eli lilly glp 1 market share of GLP-1 RAs in 2016 and 2017 Lilly's GLP-1 portfolio gains ground

Schedules slip

and Outset Medical Incorporated, two businesses that provide medical care and device technology to patients in the dialysis space, have seen their shares decline as Novo Nordisk A/S Ozempic drug showed effectiveness in patients with kidney failure

The 2024 law is bringing new requirements and restrictions meant to help level the playing field

Talk to your doctor to see if you are eligible and whether it is the best option for you

Dosing, medication choice, and program length are all personalized

For those who maintained consistent GLP-1 use, medical cost growth was six to nine percentage points lower compared to non-users, and female GLP-1 users saw a 47% reduction in hospitalizations for major cardiovascular events